It has been reported that in RRMS patients with average BMI, SOCS3 expression is reduced in leptin-sensitive immune cells during relapses, permitting unchecked leptin-induced inflammatory signaling [9] (Figure 3). Here, LEP is linked to relapsing-remitting multiple sclerosis.